<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36675095</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>13</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Reviewing the Potential Links between Viral Infections and TDP-43 Proteinopathies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1581</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24021581</ELocationID><Abstract><AbstractText>Transactive response DNA binding protein 43 kDa (TDP-43) was discovered in 2001 as a cellular factor capable to inhibit HIV-1 gene expression. Successively, it was brought to new life as the most prevalent RNA-binding protein involved in several neurological disorders, such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Despite the fact that these two research areas could be considered very distant from each other, in recent years an increasing number of publications pointed out the existence of a potentially important connection. Indeed, the ability of TDP-43 to act as an important regulator of all aspects of RNA metabolism makes this protein also a critical factor during expression of viral RNAs. Here, we summarize all recent observations regarding the involvement of TDP-43 in viral entry, replication and latency in several viruses that include enteroviruses (EVs), Theiler's murine encephalomyelitis virus (TMEV), human immunodeficiency virus (HIV), human endogenous retroviruses (HERVs), hepatitis B virus (HBV), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), West Nile virus (WNV), and herpes simplex virus-2 (HSV). In particular, in this work, we aimed to highlight the presence of similarities with the most commonly studied TDP-43 related neuronal dysfunctions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahic</LastName><ForeName>Zerina</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Saadiyat Island Campus, New York University Abu Dhabi, Abu Dhabi P.O. Box 129188, Saadiyat Island, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buratti</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1356-9074</Identifier><AffiliationInfo><Affiliation>International Centre for Genetic Engineering and Biotechnology (ICGEB), AREA Science Park, Padriciano 99, 34149 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappelli</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>International Centre for Genetic Engineering and Biotechnology (ICGEB), AREA Science Park, Padriciano 99, 34149 Trieste, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>project NOSRESCUEALS</GrantID><Agency>Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="N">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="Y">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA metabolism</Keyword><Keyword MajorTopicYN="N">RNA-binding proteins</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">neuronal dysfunctions</Keyword><Keyword MajorTopicYN="N">viral entry</Keyword><Keyword MajorTopicYN="N">viral latency</Keyword><Keyword MajorTopicYN="N">viral replication</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36675095</ArticleId><ArticleId IdType="pmc">PMC9867397</ArticleId><ArticleId IdType="doi">10.3390/ijms24021581</ArticleId><ArticleId IdType="pii">ijms24021581</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ou S.H., Wu F., Harrich D., Garc&#xed;a-Mart&#xed;nez L.F., Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 1995;69:3584&#x2013;3596. doi: 10.1128/jvi.69.6.3584-3596.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.6.3584-3596.1995</ArticleId><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Avenda&#xf1;o-V&#xe1;zquez S.E., Dhir A., Bembich S., Buratti E., Proudfoot N., Baralle F.E. Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev. 2012;26:1679&#x2013;1684. doi: 10.1101/gad.194829.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.194829.112</ArticleId><ArticleId IdType="pmc">PMC3418585</ArticleId><ArticleId IdType="pubmed">22855830</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi S., Kabuta T., Nagai Y., Tsuchiya Y., Akiyama H., Wada K. TDP-43 associates with stalled ribosomes and contributes to cell survival during cellular stress. J. Neurochem. 2013;126:288&#x2013;300. doi: 10.1111/jnc.12194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12194</ArticleId><ArticleId IdType="pubmed">23398327</ArticleId></ArticleIdList></Reference><Reference><Citation>De Conti L., Akinyi M.V., Mendoza-Maldonado R., Romano M., Baralle M., Buratti E. TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways. Nucleic Acids Res. 2015;43:8990&#x2013;9005. doi: 10.1093/nar/gkv814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv814</ArticleId><ArticleId IdType="pmc">PMC4605304</ArticleId><ArticleId IdType="pubmed">26261209</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami N.H., Smith R.B., Carrasco M.A., Williams L.A., Winborn C.S., Han S.S.W., Kiskinis E., Winborn B., Freibaum B.D., Kanagaraj A., et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81:536&#x2013;543. doi: 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel F.C., Weber S.S., Supper J., Zell A., Kahle P.J. TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR. Nucleic Acids Res. 2012;40:2668&#x2013;2682. doi: 10.1093/nar/gkr1082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr1082</ArticleId><ArticleId IdType="pmc">PMC3315294</ArticleId><ArticleId IdType="pubmed">22121224</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.C., Zhang Y., Umoh M.E., Vaughan S.W., Lorenzini I., Liu F., Sayegh M., Donlin-Asp P.G., Chen Y.H., Duong D.M., et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 2009;111:1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Duan Y., Duan G., Wang Q., Zhang K., Deng X., Qian B., Gu J., Ma Z., Zhang S., et al. Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation. Mol. Cell. 2020;79:443&#x2013;458.e7. doi: 10.1016/j.molcel.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.06.019</ArticleId><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Hwang A.W., Restrepo C.R., Yuan C.X., Trojanowski J.Q., Lee V.M.Y. An acetylation switch controls TDP-43 function and aggregation propensity. Nat. Commun. 2015;6:1&#x2013;13. doi: 10.1038/ncomms6845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6845</ArticleId><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. TDP-43 post-translational modifications in health and disease. Expert Opin. Ther. Target. 2018;22:279&#x2013;293. doi: 10.1080/14728222.2018.1439923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2018.1439923</ArticleId><ArticleId IdType="pubmed">29431050</ArticleId></ArticleIdList></Reference><Reference><Citation>Bumber J.R., Pilipovi K., Jankovi T., Dolenec P., Grzeta N., Kri J., Zupan G. Repetitive Traumatic Brain Injury Is Associated with TDP-43 Alterations, Neurodegeneration, and Glial Activation in Mice. J. Neuropathol. Exp. Neurol. 2021;80:2&#x2013;14. doi: 10.1093/jnen/nlaa130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlaa130</ArticleId><ArticleId IdType="pubmed">33212475</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E.S., Ling S.-C., Huelga S.C., Lagier-Tourenne C., Polymenidou M., Ditsworth D., Kordasiewicz H.B., McAlonis-Downes M., Platoshyn O., Parone P.A., et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl. Acad. Sci. USA. 2013;110:E736&#x2013;E745. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Humphrey J., Pickles S., Brown A.L., Hill S.E., Kachergus J.M., Shi J., Heckman M.G., Spiegel M.R., Cook C., et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Investig. 2020;130:6080&#x2013;6092. doi: 10.1172/JCI139741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139741</ArticleId><ArticleId IdType="pmc">PMC7598060</ArticleId><ArticleId IdType="pubmed">32790644</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A.-L., Wilkins O.G., Keuss M.J., Hill S.E., Zanovello M., Lee W.C., Lee F.C.Y., Masino L., Qi Y.A., Bryce-Smith S., et al. Common ALS/FTD risk variants in UNC13A exacerbate its cryptic splicing and loss upon TDP-43 mislocalization. bioRxiv. 2021 bioRxiv: 2021.04.02.438170.</Citation></Reference><Reference><Citation>Porta S., Xu Y., Restrepo C.R., Kwong L.K., Zhang B., Brown H.J., Lee E.B., Trojanowski J.Q., Lee V.M.Y. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun. 2018;9:1&#x2013;15. doi: 10.1038/s41467-018-06548-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06548-9</ArticleId><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra P.S., Boutej H., Soucy G., Bareil C., Kumar S., Picher-Martel V., Dupr&#xe9; N., Kriz J., Julien J.P. Transmission of ALS pathogenesis by the cerebrospinal fluid. Acta Neuropathol. Commun. 2020;8:1&#x2013;21. doi: 10.1186/s40478-020-00943-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00943-4</ArticleId><ArticleId IdType="pmc">PMC7206749</ArticleId><ArticleId IdType="pubmed">32381112</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler M.S., Strobel B., Freischmidt A., Helferich A.M., Kappel J., Brewer B.M., Li D., Thal D.R., Walther P., Ludolph A.C., et al. TDP-43 is intercellularly transmitted across axon terminals. J. Cell Biol. 2015;211:897&#x2013;911. doi: 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehls J., Koppensteiner H., Brack-Werner R., Floss T., Schindler M. HIV-1 replication in human immune cells is independent of TAR DNA binding protein 43 (TDP-43) expression. PLoS ONE. 2014;9:e105478. doi: 10.1371/journal.pone.0105478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105478</ArticleId><ArticleId IdType="pmc">PMC4134290</ArticleId><ArticleId IdType="pubmed">25127017</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera-Rodr&#xed;guez R., P&#xe9;rez-Yanes S., Montelongo R., Lorenzo-Salazar J.M., Est&#xe9;vez-Herrera J., Garc&#xed;a-Luis J., &#xcd;&#xf1;igo-Campos A., Rubio-Rodr&#xed;guez L.A., Mu&#xf1;oz-Barrera A., Trujillo-Gonz&#xe1;lez R., et al. Transactive Response DNA-Binding Protein (TARDBP/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6. Int. J. Mol. Sci. 2022;23:6180. doi: 10.3390/ijms23116180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23116180</ArticleId><ArticleId IdType="pmc">PMC9181786</ArticleId><ArticleId IdType="pubmed">35682862</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathore A., Iketani S., Wang P., Jia M., Sahi V., Ho D.D. CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models. Sci. Rep. 2020;10:5350. doi: 10.1038/s41598-020-62375-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62375-3</ArticleId><ArticleId IdType="pmc">PMC7093534</ArticleId><ArticleId IdType="pubmed">32210344</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y.C., Feuer R., Cashman N., Luo H. Enteroviral Infection: The Forgotten Link to Amyotrophic Lateral Sclerosis? Front. Mol. Neurosci. 2018;11:63. doi: 10.3389/fnmol.2018.00063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00063</ArticleId><ArticleId IdType="pmc">PMC5857577</ArticleId><ArticleId IdType="pubmed">29593492</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J. Sporadic amyotrophic lateral sclerosis: A hypothesis of persistent (non-lytic) enteroviral infection. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2005;6:77&#x2013;87. doi: 10.1080/14660820510027026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510027026</ArticleId><ArticleId IdType="pubmed">16036430</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y.C., Liu H., Mohamud Y., Bahreyni A., Zhang J., Cashman N.R., Luo H. Sublethal enteroviral infection exacerbates disease progression in an ALS mouse model. J. Neuroinflamm. 2022;19:1&#x2013;15. doi: 10.1186/s12974-022-02380-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02380-7</ArticleId><ArticleId IdType="pmc">PMC8753920</ArticleId><ArticleId IdType="pubmed">35022041</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung G., Shi J., Deng H., Hou J., Wang C., Hong A., Zhang J., Jia W., Luo H. Cytoplasmic translocation, aggregation, and cleavage of TDP-43 by enteroviral proteases modulate viral pathogenesis. Cell Death Differ. 2015;22:2087&#x2013;2097. doi: 10.1038/cdd.2015.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.58</ArticleId><ArticleId IdType="pmc">PMC4816113</ArticleId><ArticleId IdType="pubmed">25976304</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolbert M., Morgan C.E., Pollum M., Crespo-Hern&#xe1;ndez C.E., Li M.L., Brewer G., Tolbert B.S. HnRNP A1 Alters the Structure of a Conserved Enterovirus IRES Domain to Stimulate Viral Translation. J. Mol. Biol. 2017;429:2841&#x2013;2858. doi: 10.1016/j.jmb.2017.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2017.06.007</ArticleId><ArticleId IdType="pmc">PMC5610934</ArticleId><ArticleId IdType="pubmed">28625847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.-Y., Shih S.-R., Pan M., Li C., Lue C.-F., Stollar V., Li M.-L. hnRNP A1 interacts with the 5&#x2032; untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J. Virol. 2009;83:6106&#x2013;6114. doi: 10.1128/JVI.02476-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02476-08</ArticleId><ArticleId IdType="pmc">PMC2687368</ArticleId><ArticleId IdType="pubmed">19339352</ArticleId></ArticleIdList></Reference><Reference><Citation>Park N., Schweers N.J., Gustin K.E. Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2A(pro) J. Virol. 2015;89:11069&#x2013;11079. doi: 10.1128/JVI.00956-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00956-15</ArticleId><ArticleId IdType="pmc">PMC4621107</ArticleId><ArticleId IdType="pubmed">26311873</ArticleId></ArticleIdList></Reference><Reference><Citation>Park N., Katikaneni P., Skern T., Gustin K.E. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J. Virol. 2008;82:1647&#x2013;1655. doi: 10.1128/JVI.01670-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01670-07</ArticleId><ArticleId IdType="pmc">PMC2258732</ArticleId><ArticleId IdType="pubmed">18045934</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R., Ruller C.M., An N., Tabor-Godwin J.M., Rhoades R.E., Maciejewski S., Pagarigan R.R., Cornell C.T., Crocker S.J., Kiosses W.B., et al. Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period. J. Virol. 2009;83:9356&#x2013;9369. doi: 10.1128/JVI.02382-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02382-07</ArticleId><ArticleId IdType="pmc">PMC2738251</ArticleId><ArticleId IdType="pubmed">19570873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.Y., Hsia S.H., Huang Y.C., Wu C.T., Chang L.Y. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin. Infect. Dis. 2003;36:269&#x2013;274. doi: 10.1086/345905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/345905</ArticleId><ArticleId IdType="pubmed">12539066</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Wong J., Piesik P., Fung G., Zhang J., Jagdeo J., Li L.X., Jan E., Luo H. Cleavage of sequestosome 1/p62 by an enteroviral protease results in disrupted selective autophagy and impaired NFKB signaling. Autophagy. 2013;9:1591&#x2013;1603. doi: 10.4161/auto.26059.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.26059</ArticleId><ArticleId IdType="pubmed">23989536</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona A.K., Saulsbery H.M., Velazquez A.F.C., Jackson W.T. Enteroviruses Remodel Autophagic Trafficking through Regulation of Host SNARE Proteins to Promote Virus Replication and Cell Exit. Cell Rep. 2018;22:3304&#x2013;3314. doi: 10.1016/j.celrep.2018.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.03.003</ArticleId><ArticleId IdType="pmc">PMC5894509</ArticleId><ArticleId IdType="pubmed">29562185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd R.E. Nuclear proteins hijacked by mammalian cytoplasmic plus strand RNA viruses. Virology. 2015;479&#x2013;480:457&#x2013;474. doi: 10.1016/j.virol.2015.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.03.001</ArticleId><ArticleId IdType="pmc">PMC4426963</ArticleId><ArticleId IdType="pubmed">25818028</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoder J.D., Cifuente J.O., Pan J., Bergelson J.M., Hafenstein S. The Crystal Structure of a Coxsackievirus B3-RD Variant and a Refined 9-Angstrom Cryo-Electron Microscopy Reconstruction of the Virus Complexed with Decay-Accelerating Factor (DAF) Provide a New Footprint of DAF on the Virus Surface. J. Virol. 2012;86:12571. doi: 10.1128/JVI.01592-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01592-12</ArticleId><ArticleId IdType="pmc">PMC3497627</ArticleId><ArticleId IdType="pubmed">22973031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton H.L., Friedmann A. Purification of Theiler&#x2019;s murine encephalomyelitis virus and analysis of the structural virion polypeptides: Correlation of the polypeptide profile with virulence. J. Virol. 1980;33:1165&#x2013;1172. doi: 10.1128/jvi.33.3.1165-1172.1980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.33.3.1165-1172.1980</ArticleId><ArticleId IdType="pmc">PMC288649</ArticleId><ArticleId IdType="pubmed">6245266</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M., Toth K.S., Zhou L., Pritchard A., Lipton H.L. The structure of a highly virulent Theiler&#x2019;s murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology. 1996;220:246&#x2013;250. doi: 10.1006/viro.1996.0309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1996.0309</ArticleId><ArticleId IdType="pubmed">8659122</ArticleId></ArticleIdList></Reference><Reference><Citation>Clatch R.J., Melvold R.W., Dal Canto M.C., Miller S.D., Lipton H.L. The Theiler&#x2019;s murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B, and C. J. Neuroimmunol. 1987;15:121&#x2013;135. doi: 10.1016/0165-5728(87)90087-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-5728(87)90087-7</ArticleId><ArticleId IdType="pubmed">3584435</ArticleId></ArticleIdList></Reference><Reference><Citation>Masaki K., Sonobe Y., Ghadge G., Pytel P., Roos R.P. TDP-43 proteinopathy in Theiler&#x2019;s murine encephalomyelitis virus infection. PLoS Pathog. 2019;15:e1007574. doi: 10.1371/journal.ppat.1007574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007574</ArticleId><ArticleId IdType="pmc">PMC6390522</ArticleId><ArticleId IdType="pubmed">30742696</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Ho W.Y., Lim K., Feng J., Tucker-Kellogg G., Nave K.A., Ling S.C. Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination. Proc. Natl. Acad. Sci. USA. 2018;115:E10941&#x2013;E10950. doi: 10.1073/pnas.1809821115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1809821115</ArticleId><ArticleId IdType="pmc">PMC6243235</ArticleId><ArticleId IdType="pubmed">30373824</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia A.S., Patel P., Dutta K., Julien J.P. Inflammation Induces TDP-43 Mislocalization and Aggregation. PLoS ONE. 2015;10:e0140248. doi: 10.1371/journal.pone.0140248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140248</ArticleId><ArticleId IdType="pmc">PMC4596857</ArticleId><ArticleId IdType="pubmed">26444430</ArticleId></ArticleIdList></Reference><Reference><Citation>German Advisory Committee Blood (Arbeitskreis Blut) Human Immunodeficiency Virus (HIV) Transfus. Med. Hemother. 2016;43:203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4924471</ArticleId><ArticleId IdType="pubmed">27403093</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully C., Cawson R.A., Porter S.R. Acquired immune deficiency syndrome: Review. Br. Dent. J. 1986;161:53&#x2013;60. doi: 10.1038/sj.bdj.4805895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bdj.4805895</ArticleId><ArticleId IdType="pubmed">3524629</ArticleId></ArticleIdList></Reference><Reference><Citation>So-Armah K., Benjamin L.A., Bloomfield G.S., Feinstein M.J., Hsue P., Njuguna B., Freiberg M.S. HIV and cardiovascular disease. Lancet HIV. 2020;7:e279&#x2013;e293. doi: 10.1016/S2352-3018(20)30036-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3018(20)30036-9</ArticleId><ArticleId IdType="pmc">PMC9346572</ArticleId><ArticleId IdType="pubmed">32243826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hileman C.O., Eckard A.R., McComsey G.A. Bone loss in HIV&#x2014;A contemporary review. Curr. Opin. Endocrinol. Diabetes Obes. 2015;22:446. doi: 10.1097/MED.0000000000000200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MED.0000000000000200</ArticleId><ArticleId IdType="pmc">PMC4663974</ArticleId><ArticleId IdType="pubmed">26414081</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyatt C.M. Kidney Disease and HIV Infection. Top. Antivir. Med. 2017;25:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5677039</ArticleId><ArticleId IdType="pubmed">28402929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman K.E., Peters M.G., Thomas D. Human immunodeficiency virus and liver disease: A comprehensive update. Hepatol. Commun. 2017;1:987. doi: 10.1002/hep4.1112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep4.1112</ArticleId><ArticleId IdType="pmc">PMC5721407</ArticleId><ArticleId IdType="pubmed">30838978</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville R.N., Nath A. Human Endogenous Retrovirus-K and TDP-43 Expression Bridges ALS and HIV Neuropathology. Front. Microbiol. 2017;8:1986. doi: 10.3389/fmicb.2017.01986.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01986</ArticleId><ArticleId IdType="pmc">PMC5641584</ArticleId><ArticleId IdType="pubmed">29075249</ArticleId></ArticleIdList></Reference><Reference><Citation>Manghera M., Ferguson-Parry J., Douville R.N. TDP-43 regulates endogenous retrovirus-K viral protein accumulation. Neurobiol. Dis. 2016;94:226&#x2013;236. doi: 10.1016/j.nbd.2016.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.06.017</ArticleId><ArticleId IdType="pubmed">27370226</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandi N., Tramontano E. Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses. Front. Immunol. 2018;9:2039. doi: 10.3389/fimmu.2018.02039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02039</ArticleId><ArticleId IdType="pmc">PMC6139349</ArticleId><ArticleId IdType="pubmed">30250470</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer J., Meese E. Human endogenous retroviruses in the primate lineage and their influence on host genomes. Cytogenet. Genome Res. 2005;110:448&#x2013;456. doi: 10.1159/000084977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000084977</ArticleId><ArticleId IdType="pubmed">16093697</ArticleId></ArticleIdList></Reference><Reference><Citation>Perron H., Hamdani N., Faucard R., Lajnef M., Jamain S., Daban-Huard C., Sarrazin S., Leguen E., Houenou J., Delavest M., et al. Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder. Transl. Psychiatry. 2012;2:e201. doi: 10.1038/tp.2012.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2012.125</ArticleId><ArticleId IdType="pmc">PMC3565190</ArticleId><ArticleId IdType="pubmed">23212585</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Montojo M., de la Hera B., Varad&#xe9; J., de la Encarnaci&#xf3;n A., Camacho I., Dom&#xed;nguez-Mozo M., Arias-Leal A., Garc&#xed;a-Mart&#xed;nez &#xc1;., Casanova I., Izquierdo G., et al. HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV. Retrovirology. 2014;11:1&#x2013;10. doi: 10.1186/1742-4690-11-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-11-2</ArticleId><ArticleId IdType="pmc">PMC3892049</ArticleId><ArticleId IdType="pubmed">24405691</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Guo X., Li J., Han J., Jia L., Wen H.L., Sun C., Wang X., Zhang B., Li J., et al. Significant Upregulation of HERV-K (HML-2) Transcription Levels in Human Lung Cancer and Cancer Cells. Front. Microbiol. 2022;13:681. doi: 10.3389/fmicb.2022.850444.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.850444</ArticleId><ArticleId IdType="pmc">PMC8960717</ArticleId><ArticleId IdType="pubmed">35359739</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Lee M.H., Henderson L., Tyagi R., Bachani M., Steiner J., Campanac E., Hoffman D.A., von Geldern G., Johnson K., et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci. Transl. Med. 2015;7:307ra153. doi: 10.1126/scitranslmed.aac8201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac8201</ArticleId><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko E.J., Ock M.S., Choi Y.H., Iovanna J.L., Mun S., Han K., Kim H.S., Cha H.J. Human Endogenous Retrovirus (HERV)-K env Gene Knockout Affects Tumorigenic Characteristics of nupr1 Gene in DLD-1 Colorectal Cancer Cells. Int. J. Mol. Sci. 2021;22:3941. doi: 10.3390/ijms22083941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22083941</ArticleId><ArticleId IdType="pmc">PMC8070087</ArticleId><ArticleId IdType="pubmed">33920455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibba G., Piu C., Uleri E., Serra C., Dolei A. Disruption by SaCas9 Endonuclease of HERV-Kenv, a Retroviral Gene with Oncogenic and Neuropathogenic Potential, Inhibits Molecules Involved in Cancer and Amyotrophic Lateral Sclerosis. Viruses. 2018;10:412. doi: 10.3390/v10080412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10080412</ArticleId><ArticleId IdType="pmc">PMC6115762</ArticleId><ArticleId IdType="pubmed">30087231</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang T.J. Hepatitis B: The Virus and Disease. Hepatology. 2009;49:S13. doi: 10.1002/hep.22881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.22881</ArticleId><ArticleId IdType="pmc">PMC2809016</ArticleId><ArticleId IdType="pubmed">19399811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng L.F.P., Chan M., Chan S.H., Cheng P.C.P., Leung E.H.C., Chen W.N., Ren E.C. Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication. PLoS Med. 2005;2:0673&#x2013;0683. doi: 10.1371/journal.pmed.0020163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020163</ArticleId><ArticleId IdType="pmc">PMC1181871</ArticleId><ArticleId IdType="pubmed">16033304</ArticleId></ArticleIdList></Reference><Reference><Citation>Makokha G.N., Abe-Chayama H., Chowdhury S., Hayes C.N., Tsuge M., Yoshima T., Ishida Y., Zhang Y., Uchida T., Tateno C., et al. Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP. Sci. Rep. 2019;9:1&#x2013;18. doi: 10.1038/s41598-019-44934-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-44934-5</ArticleId><ArticleId IdType="pmc">PMC6560085</ArticleId><ArticleId IdType="pubmed">31186504</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Alnefeesi Y., Siegel A., Lui L.M.W., Teopiz K.M., Ho R.C.M., Lee Y., Nasri F., Gill H., Lin K., Cao B., et al. Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review. Front. Psychiatry. 2021;11:1629. doi: 10.3389/fpsyt.2020.621773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.621773</ArticleId><ArticleId IdType="pmc">PMC7902710</ArticleId><ArticleId IdType="pubmed">33643083</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V.C., Veras F.P., Vendramini P.H., Valen&#xe7;a A.G.F., Antunes A.S.L.M., Brand&#xe3;o-Teles C., da Silva Zuccoli G., Reis-de-Oliveira G., Silva-Costa L.C., et al. SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability. medRxiv. 2020;18:2020.10.09.20207464.</Citation></Reference><Reference><Citation>Soung A.L., Vanderheiden A., Nordvig A.S., Sissoko C.A., Canoll P., Mariani M.B., Jiang X., Bricker T., Rosoklija G.B., Arango V., et al. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain. 2022;145:4193&#x2013;4201. doi: 10.1093/brain/awac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac270</ArticleId><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Idrees D., Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochem. Biophys. Res. Commun. 2021;554:94&#x2013;98. doi: 10.1016/j.bbrc.2021.03.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.03.100</ArticleId><ArticleId IdType="pmc">PMC7988450</ArticleId><ArticleId IdType="pubmed">33789211</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidas M.J., Cosio D.S., Ali S., Kenyon N.S., Jayakumar A.R. Long-Term Sequelae of COVID-19 in Experimental Mice. Mol. Neurobiol. 2022;59:5970&#x2013;5986. doi: 10.1007/s12035-022-02932-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02932-1</ArticleId><ArticleId IdType="pmc">PMC9281331</ArticleId><ArticleId IdType="pubmed">35831558</ArticleId></ArticleIdList></Reference><Reference><Citation>Laudanski K., Hajj J., Restrepo M., Siddiq K., Okeke T., Rader D.J. Dynamic changes in central and peripheral neuro-injury vs. Neuroprotective serum markers in COVID-19 are modulated by different types of anti-viral treatments but do not affect the incidence of late and early strokes. Biomedicines. 2021;9:1791. doi: 10.3390/biomedicines9121791.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9121791</ArticleId><ArticleId IdType="pmc">PMC8698659</ArticleId><ArticleId IdType="pubmed">34944606</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer L.D., Li J., Shi P.Y. West Nile virus. Lancet Neurol. 2007;6:171&#x2013;181. doi: 10.1016/S1474-4422(07)70030-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70030-3</ArticleId><ArticleId IdType="pubmed">17239804</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar J.J., Marfin A.A. Manifestations of West Nile neuroinvasive disease. Rev. Med. Virol. 2006;16:209&#x2013;224. doi: 10.1002/rmv.501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.501</ArticleId><ArticleId IdType="pubmed">16906589</ArticleId></ArticleIdList></Reference><Reference><Citation>Constant O., Barthelemy J., Nagy A., Salinas S., Simonin Y. West Nile Virus Neuroinfection in Humans: Peripheral Biomarkers of Neuroinflammation and Neuronal Damage. Viruses. 2022;14:756. doi: 10.3390/v14040756.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040756</ArticleId><ArticleId IdType="pmc">PMC9027124</ArticleId><ArticleId IdType="pubmed">35458486</ArticleId></ArticleIdList></Reference><Reference><Citation>Looker K.J., Garnett G.P. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex. Transm. Infect. 2005;81:103. doi: 10.1136/sti.2004.012039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/sti.2004.012039</ArticleId><ArticleId IdType="pmc">PMC1764655</ArticleId><ArticleId IdType="pubmed">15800084</ArticleId></ArticleIdList></Reference><Reference><Citation>AK A.K., Mendez M.D. Herpes Simplex Encephalitis. StatPearls; Tampa, FL, USA: 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32491575</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger J.R., Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch. Neurol. 2008;65:596&#x2013;600. doi: 10.1001/archneur.65.5.596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.5.596</ArticleId><ArticleId IdType="pubmed">18474734</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera J.R., Rodr&#xed;guez-Izquierdo I., Jim&#xe9;nez J.L., Mu&#xf1;oz-Fern&#xe1;ndez M.&#xc1;. Analysis of ALS-related proteins during herpes simplex virus-2 latent infection. J. Neuroinflamm. 2020;17:1&#x2013;15. doi: 10.1186/s12974-020-02044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-02044-4</ArticleId><ArticleId IdType="pmc">PMC7722435</ArticleId><ArticleId IdType="pubmed">33287823</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaparro-Huerta V., Rivera-Cervantes M.C., Flores-Soto M.E., G&#xf3;mez-Pinedo U., Beas-Z&#xe1;rate C. Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats. J. Neuroimmunol. 2005;165:53&#x2013;62. doi: 10.1016/j.jneuroim.2005.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2005.04.025</ArticleId><ArticleId IdType="pubmed">15972237</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin W.S.T., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 1989;86:7611&#x2013;7615. doi: 10.1073/pnas.86.19.7611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.86.19.7611</ArticleId><ArticleId IdType="pmc">PMC298116</ArticleId><ArticleId IdType="pubmed">2529544</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;ll M., Berger M., Volk B., Bauer J. Occurrence of interleukin-6 in cortical plaques of Alzheimer&#x2019;s disease patients may precede transformation of diffuse into neuritic plaques. Ann. N. Y. Acad. Sci. 1996;777:205&#x2013;212. doi: 10.1111/j.1749-6632.1996.tb34420.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1996.tb34420.x</ArticleId><ArticleId IdType="pubmed">8624085</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Wal E.A., G&#xf3;mez-Pinilla F., Cotmarv C.W. Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport. 1993;4:69&#x2013;72. doi: 10.1097/00001756-199301000-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199301000-00018</ArticleId><ArticleId IdType="pubmed">8453039</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanct&#xf4;t K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry. 2010;67:446&#x2013;457. doi: 10.1016/j.biopsych.2009.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2009.09.033</ArticleId><ArticleId IdType="pubmed">20015486</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C.-H., Allen K., Oei F., Leoni E., Kuhle J., Tree T., Fratta P., Sharma N., Sidle K., Howard R., et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2016;3:e244. doi: 10.1212/NXI.0000000000000244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000244</ArticleId><ArticleId IdType="pmc">PMC4897985</ArticleId><ArticleId IdType="pubmed">27308305</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;gren M., Folkesson S., Blennow K. Increased intrathecal inflammatory activity in frontotemporal dementia: Pathophysiological implications. J. Neurol. Neurosurg. Psychiatry. 2004;75:1107&#x2013;1111. doi: 10.1136/jnnp.2003.019422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2003.019422</ArticleId><ArticleId IdType="pmc">PMC1739153</ArticleId><ArticleId IdType="pubmed">15258209</ArticleId></ArticleIdList></Reference><Reference><Citation>Boss&#xf9; P., Salani F., Alberici A., Archetti S., Bellelli G., Galimberti D., Scarpini E., Spalletta G., Caltagirone C., Padovani A., et al. Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients. J. Neuroinflamm. 2011;8:65. doi: 10.1186/1742-2094-8-65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-65</ArticleId><ArticleId IdType="pmc">PMC3141503</ArticleId><ArticleId IdType="pubmed">21645364</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons L., Rollinson S., Thompson J.C., Robinson A., Davidson Y.S., Richardson A., Neary D., Pickering-Brown S.M., Snowden J.S., Mann D.M.A. Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration. Neurobiol. Aging. 2015;36:1603.e1. doi: 10.1016/j.neurobiolaging.2014.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.023</ArticleId><ArticleId IdType="pmc">PMC4504979</ArticleId><ArticleId IdType="pubmed">25435337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner R., Myers R.R. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport. 1996;7:2897&#x2013;2901. doi: 10.1097/00001756-199611250-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199611250-00018</ArticleId><ArticleId IdType="pubmed">9116205</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorkin L.S., Doom C.M. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat. J. Peripher. Nerv. Syst. 2000;5:96&#x2013;100. doi: 10.1046/j.1529-8027.2000.00012.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1529-8027.2000.00012.x</ArticleId><ArticleId IdType="pubmed">10905468</ArticleId></ArticleIdList></Reference><Reference><Citation>Neniskyte U., Vilalta A., Brown G.C. Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis. FEBS Lett. 2014;588:2952. doi: 10.1016/j.febslet.2014.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.05.046</ArticleId><ArticleId IdType="pmc">PMC4158418</ArticleId><ArticleId IdType="pubmed">24911209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H.J., Fu Y.Y., Wei Q.Q., Zhang Z.J. Neuroinflammation in HIV-Related Neuropathic Pain. Front. Pharmacol. 2021;12:653852. doi: 10.3389/fphar.2021.653852.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.653852</ArticleId><ArticleId IdType="pmc">PMC8093869</ArticleId><ArticleId IdType="pubmed">33959022</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan D.S., Miller S.D. CNS Expression of B7-H1 Regulates Pro-Inflammatory Cytokine Production and Alters Severity of Theiler&#x2019;s Virus-Induced Demyelinating Disease. PLoS ONE. 2011;6:18548. doi: 10.1371/journal.pone.0018548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0018548</ArticleId><ArticleId IdType="pmc">PMC3072984</ArticleId><ArticleId IdType="pubmed">21494618</ArticleId></ArticleIdList></Reference><Reference><Citation>Faucard R., Madeira A., Gehin N., Authier F.J., Panaite P.A., Lesage C., Burgelin I., Bertel M., Bernard C., Curtin F., et al. Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. EBioMedicine. 2016;6:190. doi: 10.1016/j.ebiom.2016.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2016.03.001</ArticleId><ArticleId IdType="pmc">PMC4856744</ArticleId><ArticleId IdType="pubmed">27211560</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarland A.J., Yousuf M.S., Shiers S., Price T.J. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: Implications for COVID-19 and pain. Pain Rep. 2021;6:e885. doi: 10.1097/PR9.0000000000000885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000885</ArticleId><ArticleId IdType="pmc">PMC7803673</ArticleId><ArticleId IdType="pubmed">33458558</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T.Y., Chen K.Y., Jhan K.Y., Li C.H., Jung S.M., Wang L.C. Temporal-spatial expressions of interleukin-4, interleukin-10, and interleukin-13 in the brains of C57BL/6 and BALB/c mice infected with Angiostrongylus cantonensis: An immunohistochemical study. J. Microbiol. Immunol. Infect. 2020;53:592&#x2013;603. doi: 10.1016/j.jmii.2018.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2018.10.010</ArticleId><ArticleId IdType="pubmed">30600200</ArticleId></ArticleIdList></Reference><Reference><Citation>Szel&#xe9;nyi J. Cytokines and the central nervous system. Brain Res. Bull. 2001;54:329&#x2013;338. doi: 10.1016/S0361-9230(01)00428-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0361-9230(01)00428-2</ArticleId><ArticleId IdType="pubmed">11306183</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidoryk-Wegrzynowicz M., Wegrzynowicz M., Lee E., Bowman A.B., Aschner M. Role of astrocytes in brain function and disease. Toxicol. Pathol. 2011;39:115&#x2013;123. doi: 10.1177/0192623310385254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0192623310385254</ArticleId><ArticleId IdType="pmc">PMC6218934</ArticleId><ArticleId IdType="pubmed">21075920</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R.S., Garber C., Funk K.E., Salimi H., Soung A., Kanmogne M., Manivasagam S., Agner S., Cain M. Neuroinflammation during RNA Viral Infections. Annu. Rev. Immunol. 2019;37:73. doi: 10.1146/annurev-immunol-042718-041417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041417</ArticleId><ArticleId IdType="pmc">PMC6731125</ArticleId><ArticleId IdType="pubmed">31026414</ArticleId></ArticleIdList></Reference><Reference><Citation>de Conti L., Baralle M., Buratti E. Neurodegeneration and RNA-binding proteins. Wiley Interdiscip. Rev. RNA. 2016;8:1&#x2013;12. doi: 10.1002/wrna.1394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1394</ArticleId><ArticleId IdType="pubmed">27659427</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Hamilton R., Salapa H.E., Levin M.C. Pro-Inflammatory Cytokines and Antibodies Induce hnRNP A1 Dysfunction in Mouse Primary Cortical Neurons. Brain Sci. 2021;11:1282. doi: 10.3390/brainsci11101282.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11101282</ArticleId><ArticleId IdType="pmc">PMC8533849</ArticleId><ArticleId IdType="pubmed">34679349</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao L., Liu S., Li Y., Yang G., Luo Y., Li S., Du H., Zhao Y., Wang D., Chen J., et al. The Nuclear Matrix Protein SAFA Surveils Viral RNA and Facilitates Immunity by Activating Antiviral Enhancers and Super-enhancers. Cell Host Microbe. 2019;26:369&#x2013;384.e8. doi: 10.1016/j.chom.2019.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.08.010</ArticleId><ArticleId IdType="pubmed">31513772</ArticleId></ArticleIdList></Reference><Reference><Citation>Appocher C., Mohagheghi F., Cappelli S., Stuani C., Romano M., Feiguin F., Buratti E. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. Nucleic Acids Res. 2017;45:8026&#x2013;8045. doi: 10.1093/nar/gkx477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx477</ArticleId><ArticleId IdType="pmc">PMC5570092</ArticleId><ArticleId IdType="pubmed">28575377</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappelli S., Romano M., Buratti E. Systematic Analysis of Gene Expression Profiles Controlled by hnRNP Q and hnRNP R, Two Closely Related Human RNA Binding Proteins Implicated in mRNA Processing Mechanisms. Front. Mol. Biosci. 2018;5:1&#x2013;17. doi: 10.3389/fmolb.2018.00079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2018.00079</ArticleId><ArticleId IdType="pmc">PMC6125337</ArticleId><ArticleId IdType="pubmed">30214903</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata H., Hattori T., Maeda H., Takashiba S., Takigawa M., Kido J., Nagata T. Identification of transactivation-responsive DNA-binding protein 43 (TARDBP43; TDP-43) as a novel factor for TNF-&#x3b1; expression upon lipopolysaccharide stimulation in human monocytes. J. Periodontal Res. 2015;50:452&#x2013;460. doi: 10.1111/jre.12227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jre.12227</ArticleId><ArticleId IdType="pubmed">25202836</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;u&#x161;njar U., &#x160;krabar N., Brown A.L., Abbassi Y., Phatnani H., Phatnani H., Fratta P., Kwan J., Sareen D., Broach J.R., et al. Cell environment shapes TDP-43 function with implications in neuronal and muscle disease. Commun. Biol. 2022;5:1&#x2013;17. doi: 10.1038/s42003-022-03253-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03253-8</ArticleId><ArticleId IdType="pmc">PMC8983780</ArticleId><ArticleId IdType="pubmed">35383280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.J., Benveniste E.N. Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 1999;98:77&#x2013;88. doi: 10.1016/S0165-5728(99)00084-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(99)00084-3</ArticleId><ArticleId IdType="pubmed">10430040</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J., Wang P., Bai F., Town T., Fikrig E. ICAM-1 Participates in the Entry of West Nile Virus into the Central Nervous System. J. Virol. 2008;82:4164. doi: 10.1128/JVI.02621-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02621-07</ArticleId><ArticleId IdType="pmc">PMC2292986</ArticleId><ArticleId IdType="pubmed">18256150</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller N. The role of intercellular adhesion molecule-1 in the pathogenesis of psychiatric disorders. Front. Pharmacol. 2019;10:1251. doi: 10.3389/fphar.2019.01251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01251</ArticleId><ArticleId IdType="pmc">PMC6883971</ArticleId><ArticleId IdType="pubmed">31824303</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama H., Kawamata T., Yamada T., Tooyama I., Ishii T., McGeer P.L. Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders. Acta Neuropathol. 1993;85:628&#x2013;634. doi: 10.1007/BF00334673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00334673</ArticleId><ArticleId IdType="pubmed">8337942</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Cao M.C., Jansson D., Rustenhoven J., Smyth L.C.D., Aalderink M.C., Siemens A., Fan V., Wu J., Mee E.W., et al. The amyotrophic lateral sclerosis-linked protein TDP-43 regulates interleukin-6 cytokine production by human brain pericytes. Mol. Cell Neurosci. 2022;123:103768. doi: 10.1016/j.mcn.2022.103768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2022.103768</ArticleId><ArticleId IdType="pubmed">36038081</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Kim S., Kang H.Y., Lim H.R., Kwon Y., Jo M., Jeon Y.M., Kim S.R., Kim K., Ha C.M., et al. The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response. J. Neuroinflamm. 2020;17:1&#x2013;22. doi: 10.1186/s12974-020-01963-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01963-6</ArticleId><ArticleId IdType="pmc">PMC7556969</ArticleId><ArticleId IdType="pubmed">33054766</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Lee T.A., Lee E., Kang S., Park A., Kim S.W., Park H.J., Yoon J.H., Ha S.J., Park T., et al. Identification of a subnuclear body involved in sequence-specific cytokine RNA processing. Nat. Commun. 2015;6:5791. doi: 10.1038/ncomms6791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6791</ArticleId><ArticleId IdType="pubmed">25557830</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T., Narazaki M., Kishimoto T. IL-6 in Inflammation, Immunity, and Disease. Cold Spring Harb. Perspect. Biol. 2014;6:16295&#x2013;16296. doi: 10.1101/cshperspect.a016295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a016295</ArticleId><ArticleId IdType="pmc">PMC4176007</ArticleId><ArticleId IdType="pubmed">25190079</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouezzedine F., Fardel O., Gripon P. Interleukin 6 inhibits HBV entry through NTCP down regulation. Virology. 2015;481:34&#x2013;42. doi: 10.1016/j.virol.2015.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.026</ArticleId><ArticleId IdType="pubmed">25765005</ArticleId></ArticleIdList></Reference><Reference><Citation>Palumbo G.A., Scisciani C., Pediconi N., Lupacchini L., Alfalate D., Guerrieri F., Calvo L., Salerno D., di Cocco S., Levrero M., et al. IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome. PLoS ONE. 2015;10:e0142599. doi: 10.1371/journal.pone.0142599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142599</ArticleId><ArticleId IdType="pmc">PMC4651563</ArticleId><ArticleId IdType="pubmed">26580974</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;sel M., Quasdorff M., Wiegmann K., Webb D., Zedler U., Broxtermann M., Tedjokusumo R., Esser K., Arzberger S., Kirschning C.J., et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology. 2009;50:1773&#x2013;1782. doi: 10.1002/hep.23226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.23226</ArticleId><ArticleId IdType="pubmed">19937696</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulhaq Z.S., Soraya G.V. Interleukin-6 as a potential biomarker of COVID-19 progression. Med. Mal. Infect. 2020;50:382&#x2013;383. doi: 10.1016/j.medmal.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medmal.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7129451</ArticleId><ArticleId IdType="pubmed">32259560</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Xie J., Yin M., Yang Y., Ding C., Gao Y., Ma X. Interleukin-6 and severity of COVID-19 patients in Hefei, China. Med. Mal. Infect. 2020;50:629&#x2013;631. doi: 10.1016/j.medmal.2020.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medmal.2020.06.005</ArticleId><ArticleId IdType="pmc">PMC7316053</ArticleId><ArticleId IdType="pubmed">32593746</ArticleId></ArticleIdList></Reference><Reference><Citation>Trovato M., Ruggeri R.M., Sciacchitano S., Vicchio T.M., Picerno I., Pellican&#xf2; G., Valenti A., Visalli G. Serum interleukin-6 levels are increased in HIV-infected patients that develop autoimmune disease during long-term follow-up. Immunobiology. 2018;223:264&#x2013;268. doi: 10.1016/j.imbio.2017.10.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2017.10.039</ArticleId><ArticleId IdType="pubmed">29055566</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Xia K., Chen L., Fan D. Increased interleukin-6 levels in the astrocyte-derived exosomes of sporadic amyotrophic lateral sclerosis patients. Front. Neurosci. 2019;13:574. doi: 10.3389/fnins.2019.00574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00574</ArticleId><ArticleId IdType="pmc">PMC6560167</ArticleId><ArticleId IdType="pubmed">31231184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann K.W., Schuh A.F.S., Saute J., Townsend R., Fricke D., Leke R., Souza D.O., Portela L.V., Chaves M.L.F., Rieder C.R.M. Interleukin-6 serum levels in patients with Parkinson&#x2019;s disease. Neurochem. Res. 2009;34:1401&#x2013;1404. doi: 10.1007/s11064-009-9921-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-009-9921-z</ArticleId><ArticleId IdType="pubmed">19214748</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Yolk B., Berger M. Interleukin-6 and &#x3b1;-2-macroglobulin indicate an acute-phase state in Alzheimer&#x2019;s disease cortices. FEBS Lett. 1991;285:111&#x2013;114. doi: 10.1016/0014-5793(91)80737-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(91)80737-N</ArticleId><ArticleId IdType="pubmed">1712317</ArticleId></ArticleIdList></Reference><Reference><Citation>Wertz M.H., Pineda S.S., Lee H., Kulicke R., Kellis M., Heiman M. Interleukin-6 deficiency exacerbates Huntington&#x2019;s disease model phenotypes. Mol. Neurodegener. 2020;15:1&#x2013;8. doi: 10.1186/s13024-020-00379-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00379-3</ArticleId><ArticleId IdType="pmc">PMC7247164</ArticleId><ArticleId IdType="pubmed">32448329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Castejon G., Brough D. Understanding the mechanism of IL-1&#x3b2; secretion. Cytokine Growth Factor Rev. 2011;22:189. doi: 10.1016/j.cytogfr.2011.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2011.10.001</ArticleId><ArticleId IdType="pmc">PMC3714593</ArticleId><ArticleId IdType="pubmed">22019906</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendiola A.S., Cardona A.E. The IL-1&#x3b2; phenomena in neuroinflammatory diseases. J. Neural Transm. 2018;125:781. doi: 10.1007/s00702-017-1732-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-017-1732-9</ArticleId><ArticleId IdType="pmc">PMC5699978</ArticleId><ArticleId IdType="pubmed">28534174</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhang L., Joo D., Sun S.C. NF-&#x3ba;B signaling in inflammation. Signal Transduct. Target. Ther. 2017;2:1&#x2013;9. doi: 10.1038/sigtrans.2017.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F., Molawi K., Zychlinsky A. Mutant superoxide dismutase 1-induced IL-1&#x3b2; accelerates ALS pathogenesis. Proc. Natl. Acad. Sci. USA. 2010;107:13046&#x2013;13050. doi: 10.1073/pnas.1002396107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002396107</ArticleId><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Cioccarelli C., S&#xe1;nchez-Rodr&#xed;guez R., Angioni R., Venegas F.C., Bertoldi N., Munari F., Cattelan A., Molon B., Viola A. IL1&#x3b2; Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry through the p38 MAPK-GATA2 Axis. Front. Immunol. 2021;12:5173. doi: 10.3389/fimmu.2021.781352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.781352</ArticleId><ArticleId IdType="pmc">PMC8691651</ArticleId><ArticleId IdType="pubmed">34950146</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosio C., Valle C., Casciati A., Iaccarino C., Carr&#xec; M.T. Astroglial inhibition of NF-&#x3ba;B does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS) PLoS ONE. 2011;6:e17187. doi: 10.1371/journal.pone.0017187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017187</ArticleId><ArticleId IdType="pmc">PMC3060799</ArticleId><ArticleId IdType="pubmed">21445241</ArticleId></ArticleIdList></Reference><Reference><Citation>Krabbe G., Minami S.S., Etchegaray J.I., Taneja P., Djukic B., Davalos D., Le D., Lo I., Zhan L., Reichert M.C., et al. Microglial NF&#x3ba;B-TNF&#x3b1; hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia. Proc. Natl. Acad. Sci. USA. 2017;114:5029&#x2013;5034. doi: 10.1073/pnas.1700477114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1700477114</ArticleId><ArticleId IdType="pmc">PMC5441749</ArticleId><ArticleId IdType="pubmed">28438992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.P., Ruberg M., Faucheux B.A., Agid Y., Hirsch E.C. Nuclear translocation of NF-&#x3ba;B is increased in dopaminergic neurons of patients with Parkinson&#x2009;disease. Proc. Natl. Acad. Sci. USA. 1997;94:7531. doi: 10.1073/pnas.94.14.7531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.14.7531</ArticleId><ArticleId IdType="pmc">PMC23856</ArticleId><ArticleId IdType="pubmed">9207126</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao H.Y., Chen Y.C., Chen H.M., Tu P.H., Chern Y. A critical role of astrocyte-mediated nuclear factor-&#x3ba;B-dependent inflammation in Huntington&#x2019;s disease. Hum. Mol. Genet. 2013;22:1826&#x2013;1842. doi: 10.1093/hmg/ddt036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt036</ArticleId><ArticleId IdType="pubmed">23372043</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircheis R., Haasbach E., Lueftenegger D., Heyken W.T., Ocker M., Planz O. NF-&#x3ba;B Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. Front. Immunol. 2020;11:3446. doi: 10.3389/fimmu.2020.598444.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.598444</ArticleId><ArticleId IdType="pmc">PMC7759159</ArticleId><ArticleId IdType="pubmed">33362782</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J., Zhou H., Wang F., Xia X., Sun Q., Wang R., Cheng B. The hepatitis B virus X protein downregulates NF-&#x3ba;B signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells. Int. J. Oncol. 2013;42:1636&#x2013;1643. doi: 10.3892/ijo.2013.1842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2013.1842</ArticleId><ArticleId IdType="pubmed">23450368</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiume G., Vecchio E., de Laurentiis A., Trimboli F., Palmieri C., Pisano A., Falcone C., Pontoriero M., Rossi A., Scialdone A., et al. Human immunodeficiency virus-1 Tat activates NF-&#x3ba;B via physical interaction with I&#x3ba;B-&#x3b1; and p65. Nucleic Acids Res. 2012;40:3548&#x2013;3562. doi: 10.1093/nar/gkr1224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr1224</ArticleId><ArticleId IdType="pmc">PMC3333881</ArticleId><ArticleId IdType="pubmed">22187158</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink D.L., Cai J., Whelan M.V.X., Monit C., de Motes C.M., Towers G.J., Sumner R.P. HIV-2/SIV Vpx antagonises NF-&#x3ba;B activation by targeting p65. Retrovirology. 2022;19:1&#x2013;14. doi: 10.1186/s12977-021-00586-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12977-021-00586-w</ArticleId><ArticleId IdType="pmc">PMC8785589</ArticleId><ArticleId IdType="pubmed">35073912</ArticleId></ArticleIdList></Reference><Reference><Citation>Saura M., Lizarbe T.R., Rama-Pacheco C., Lowenstein C.J., Zaragoza C. Cell Cycle Inhibitor of NF&#x3ba;B Alpha is a Host Sensor of Coxsackievirus Infection. Cell Cycle. 2007;6:503&#x2013;506. doi: 10.4161/cc.6.5.3918.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.6.5.3918</ArticleId><ArticleId IdType="pubmed">17351338</ArticleId></ArticleIdList></Reference><Reference><Citation>Amici C., Rossi A., Costanzo A., Ciafr&#xe8; S., Marinari B., Balsamo M., Levrero M., Santoro M.G. Herpes simplex virus disrupts NF-&#x3ba;B regulation by blocking its recruitment on the I&#x3ba;B&#x3b1; promoter and directing the factor on viral genes. J. Biol. Chem. 2006;281:7110&#x2013;7117. doi: 10.1074/jbc.M512366200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M512366200</ArticleId><ArticleId IdType="pubmed">16407234</ArticleId></ArticleIdList></Reference><Reference><Citation>Enguita F.J., Leit&#xe3;o A.L., McDonald J.T., Zaksas V., Das S., Galeano D., Taylor D., Wurtele E.S., Saravia-Butler A., Baylin S.B., et al. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response. Theranostics. 2022;12:3946. doi: 10.7150/thno.73268.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.73268</ArticleId><ArticleId IdType="pmc">PMC9131284</ArticleId><ArticleId IdType="pubmed">35664076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginn L., la Montagna M., Wu Q., Shi L. Diverse roles of long non-coding RNAs in viral diseases. Rev. Med. Virol. 2021;31:e2198. doi: 10.1002/rmv.2198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2198</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsukawa K., Kukharsky M.S., Park S.K., Park S., Watanabe N., Iwatsubo T., Hashimoto T., Liebman S.W., Shelkovnikova T.A. Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy. RNA Biol. 2021;18:1546. doi: 10.1080/15476286.2020.1860580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1860580</ArticleId><ArticleId IdType="pmc">PMC8583295</ArticleId><ArticleId IdType="pubmed">33427561</ArticleId></ArticleIdList></Reference><Reference><Citation>An H., Williams N.G., Shelkovnikova T.A. NEAT1 and paraspeckles in neurodegenerative diseases: A missing lnc found? Noncoding RNA Res. 2018;3:243&#x2013;252. doi: 10.1016/j.ncrna.2018.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2018.11.003</ArticleId><ArticleId IdType="pmc">PMC6257911</ArticleId><ArticleId IdType="pubmed">30533572</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya S., Vrati S. The Malat1 long non-coding RNA is upregulated by signalling through the PERK axis of unfolded protein response during flavivirus infection. Sci. Rep. 2015;5:1&#x2013;8. doi: 10.1038/srep17794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep17794</ArticleId><ArticleId IdType="pmc">PMC4669524</ArticleId><ArticleId IdType="pubmed">26634309</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Li Y., Fang S., Jiang B., Qin C., Xie P., Zhou G., Li G. The role of MALAT1 correlates with HPV in cervical cancer. Oncol. Lett. 2014;7:2135&#x2013;2141. doi: 10.3892/ol.2014.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2014.1996</ArticleId><ArticleId IdType="pmc">PMC4049771</ArticleId><ArticleId IdType="pubmed">24932303</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Wang Z., Liu L., Yang Z., Liu S., Ma Z., Liu Y., Ma Y., Zhang L., Zhang X., et al. LncRNA Malat1 inhibition of TDP43 cleavage suppresses IRF3-initiated antiviral innate immunity. Proc. Natl. Acad. Sci. USA. 2020;117:23695&#x2013;23706. doi: 10.1073/pnas.2003932117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003932117</ArticleId><ArticleId IdType="pmc">PMC7519350</ArticleId><ArticleId IdType="pubmed">32907941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Chen C.Y., Yedavalli V.S.R.K., Jeang K.T. NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. mBio. 2013;4:e00596-12. doi: 10.1128/mBio.00596-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00596-12</ArticleId><ArticleId IdType="pmc">PMC3560530</ArticleId><ArticleId IdType="pubmed">23362321</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Fan P., Zhao Y., Zhang S., Lu J., Xie W., Jiang Y., Lei F., Xu N., Zhang Y. NEAT1 modulates herpes simplex virus-1 replication by regulating viral gene transcription. Cell. Mol. Life Sci. 2017;74:1117. doi: 10.1007/s00018-016-2398-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2398-4</ArticleId><ArticleId IdType="pmc">PMC5309293</ArticleId><ArticleId IdType="pubmed">27783096</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Baralle F.E. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci. 2008;13:867&#x2013;878. doi: 10.2741/2727.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2727</ArticleId><ArticleId IdType="pubmed">17981595</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann J., Monette A., Tripathy V., S&#xf3;jka A., Abo-Rady M., Janosh A., Bhatnagar R., Bickle M., Mouland A.J., Sterneckert J. Viral Infections Exacerbate FUS-ALS Phenotypes in iPSC-Derived Spinal Neurons in a Virus Species-Specific Manner. Front. Cell Neurosci. 2019;13:480. doi: 10.3389/fncel.2019.00480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00480</ArticleId><ArticleId IdType="pmc">PMC6817715</ArticleId><ArticleId IdType="pubmed">31695598</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. Targeting TDP-43 proteinopathy with drugs and drug-like small molecules. Br. J. Pharmacol. 2021;178:1298&#x2013;1315. doi: 10.1111/bph.15148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15148</ArticleId><ArticleId IdType="pubmed">32469420</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollasalehi N., Francois-Moutal L., Scott D.D., Tello J.A., Williams H., Mahoney B., Carlson J.M., Dong Y., Li X., Miranda V.G., et al. An Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43 Yields Neuroprotective Properties. ACS Chem. Biol. 2020;15:2854&#x2013;2859. doi: 10.1021/acschembio.0c00494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.0c00494</ArticleId><ArticleId IdType="pmc">PMC8548910</ArticleId><ArticleId IdType="pubmed">33044808</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandare V.V., Ramaswamy A. Identification of possible siRNA molecules for TDP43 mutants causing amyotrophic lateral sclerosis: In silico design and molecular dynamics study. Comput. Biol. Chem. 2016;61:97&#x2013;108. doi: 10.1016/j.compbiolchem.2016.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiolchem.2016.01.001</ArticleId><ArticleId IdType="pubmed">26854610</ArticleId></ArticleIdList></Reference><Reference><Citation>Sckaff M., Gill K., Sachdev A., Birk A., Arogundade O.A., Watry H., Keough K., Tsai Y.-C., Ziegle J., Conklin B., et al. Two therapeutic CRISPR/Cas9 gene editing approaches revert FTD/ALS cellular pathology caused by a C9orf72 repeat expansion mutation in patient derived cells. bioRxiv. 2022 bioRxiv: 2022.05.21.492887.</Citation></Reference><Reference><Citation>Becker L.A., Huang B., Bieri G., Ma R., Knowles D.A., Jafar-Nejad P., Messing J., Kim H.J., Soriano A., Auburger G., et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. 2017;544:367&#x2013;371. doi: 10.1038/nature22038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22038</ArticleId><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadi M., Anyango S., Deshpande M., Nair S., Natassia C., Yordanova G., Yuan D., Stroe O., Wood G., Laydon A., et al. AlphaFold Protein Structure Database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022;50:D439&#x2013;D444. doi: 10.1093/nar/gkab1061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1061</ArticleId><ArticleId IdType="pmc">PMC8728224</ArticleId><ArticleId IdType="pubmed">34791371</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper J., Evans R., Pritzel A., Green T., Figurnov M., Ronneberger O., Tunyasuvunakool K., Bates R., &#x17d;&#xed;dek A., Potapenko A., et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583&#x2013;589. doi: 10.1038/s41586-021-03819-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03819-2</ArticleId><ArticleId IdType="pmc">PMC8371605</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R., Mena I., Pagarigan R.R., Harkins S., Hassett D.E., Whitton J.L. Coxsackievirus B3 and the Neonatal CNS: The Roles of Stem Cells, Developing Neurons, and Apoptosis in Infection, Viral Dissemination, and Disease. Am. J. Pathol. 2003;163:1379. doi: 10.1016/S0002-9440(10)63496-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63496-7</ArticleId><ArticleId IdType="pmc">PMC1868316</ArticleId><ArticleId IdType="pubmed">14507646</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.H., Lau C.S., Cheng P.K.C., Ng A.Y.Y., Lim W.W.L. Coxsackievirus B3-associated aseptic meningitis: An emerging infection in Hong Kong. J. Med. Virol. 2011;83:483&#x2013;489. doi: 10.1002/jmv.21998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21998</ArticleId><ArticleId IdType="pubmed">21264869</ArticleId></ArticleIdList></Reference><Reference><Citation>Omura S., Kawai E., Sato F., Martinez N.E., Minagar A., Al-Kofahi M., Yun J.W., Cvek U., Trutschl M., Alexander J.S., et al. Theiler&#x2019;s Virus-Mediated Immunopathology in the CNS and Heart: Roles of Organ-Specific Cytokine and Lymphatic Responses. Front. Immunol. 2018;9:2870. doi: 10.3389/fimmu.2018.02870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02870</ArticleId><ArticleId IdType="pmc">PMC6295469</ArticleId><ArticleId IdType="pubmed">30619258</ArticleId></ArticleIdList></Reference><Reference><Citation>Zink W.E., Zheng J., Persidsky Y., Poluektova L., Gendelman H.E. The neuropathogenesis of HIV-1 infection. FEMS Immunol. Med. Microbiol. 1999;26:233&#x2013;241. doi: 10.1111/j.1574-695X.1999.tb01394.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.1999.tb01394.x</ArticleId><ArticleId IdType="pubmed">10575134</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen L.N., Smith B., Reich D., Quezado M., Nath A. HIV-associated opportunistic CNS infections: Pathophysiology, diagnosis and treatment. Nat. Rev. Neurol. 2016;12:662&#x2013;674. doi: 10.1038/nrneurol.2016.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.149</ArticleId><ArticleId IdType="pubmed">27786246</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;ger V., Emmer A., Staege M.S., Cynis H. Endogenous Retroviruses in Nervous System Disorders. Pharmaceuticals. 2021;14:70. doi: 10.3390/ph14010070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14010070</ArticleId><ArticleId IdType="pmc">PMC7829834</ArticleId><ArticleId IdType="pubmed">33467098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S., Guo Z., Chen S., Lin X., Ye M., Qiu Y. Progressive Brain Structural Impairment Assessed via Network and Causal Analysis in Patients with Hepatitis B Virus-Related Cirrhosis. Front. Neurol. 2022;13:849571. doi: 10.3389/fneur.2022.849571.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.849571</ArticleId><ArticleId IdType="pmc">PMC9120530</ArticleId><ArticleId IdType="pubmed">35599731</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V.C., Veras F.P., Silva L.S., Nogueira M.H., Antunes A.S.L.M., Vendramini P.H., Valen&#xe7;a A.G.F., Brand&#xe3;o-Teles C., da Silva Zuccoli G., et al. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc. Natl. Acad. Sci. USA. 2022;119:e2200960119. doi: 10.1073/pnas.2200960119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J. SARS-CoV-2, aging, and Post-COVID-19 neurodegeneration. J. Neurochem. 2022. ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15736</ArticleId><ArticleId IdType="pmc">PMC9877664</ArticleId><ArticleId IdType="pubmed">36458986</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart J., Tillman G., Kraut M.A., Chiang H.S., Strain J.F., Li Y., Agrawal A.G., Jester P., Gnann J.W., Whitley R.J. West Nile virus neuroinvasive disease: Neurological manifestations and prospective longitudinal outcomes. BMC Infect. Dis. 2014;14:1&#x2013;10. doi: 10.1186/1471-2334-14-248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-248</ArticleId><ArticleId IdType="pmc">PMC4020876</ArticleId><ArticleId IdType="pubmed">24884681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi S., Orba Y., Yamaguchi H., Kimura T., Sawa H. Accumulation of ubiquitinated proteins is related to West Nile virus-induced neuronal apoptosis. Neuropathology. 2012;32:398&#x2013;405. doi: 10.1111/j.1440-1789.2011.01275.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2011.01275.x</ArticleId><ArticleId IdType="pubmed">22129084</ArticleId></ArticleIdList></Reference><Reference><Citation>Garber C., Soung A., Vollmer L.L., Kanmogne M., Last A., Brown J., Klein R.S. T cells promote microglia-mediated synaptic elimination and cognitive dysfunction during recovery from neuropathogenic flaviviruses. Nat. Neurosci. 2019;22:1276&#x2013;1288. doi: 10.1038/s41593-019-0427-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0427-y</ArticleId><ArticleId IdType="pmc">PMC6822175</ArticleId><ArticleId IdType="pubmed">31235930</ArticleId></ArticleIdList></Reference><Reference><Citation>Garber C., Vasek M.J., Vollmer L.L., Sun T., Jiang X., Klein R.S. Astrocytes decrease adult neurogenesis during virus-induced memory dysfunction via IL-1. Nat. Immunol. 2018;19:151&#x2013;161. doi: 10.1038/s41590-017-0021-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-017-0021-y</ArticleId><ArticleId IdType="pmc">PMC5786497</ArticleId><ArticleId IdType="pubmed">29292385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zukor K., Wang H., Hurst B.L., Siddharthan V., van Wettere A., Pilowsky P.M., Morrey J.D. Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters. J. Neurovirol. 2017;23:186&#x2013;204. doi: 10.1007/s13365-016-0488-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-016-0488-6</ArticleId><ArticleId IdType="pmc">PMC5332528</ArticleId><ArticleId IdType="pubmed">27761801</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis T.P., Imai Y., Yang L., Vallas V., Krause P.R. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: Role of latency-associated transcripts. J. Virol. 2007;81:1872&#x2013;1878. doi: 10.1128/JVI.02110-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02110-06</ArticleId><ArticleId IdType="pmc">PMC1797553</ArticleId><ArticleId IdType="pubmed">17151134</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>